Evernow advertises online menopause care with both pay-per-visit and membership features. That can sound simple until you try to work out which services belong to the membership and which have their own price or insurance rules.
We reviewed Evernow’s official homepage, FAQ, and a separate enrollment offer on September 23, 2026. The pages did not all display the same annual membership figure, so this review preserves that discrepancy instead of presenting one promotional number as a universal price.
Confirm your actual enrollment terms and distinguish membership, visits, and medication before paying.
Two ways of describing access
Evernow’s FAQ describes pay-per-visit care, with insurance or a self-pay visit option, and a separate membership offering. The public explanation includes a period of portal and medication access after a visit. That language should not be read as an unlimited clinical service without checking the terms.
Ask which model you are selecting, how communication with the care team works, and whether a video appointment is required or charged separately. A membership is a service arrangement; a prescription still depends on clinical evaluation. The HRT overview explains the medical questions that a payment screen cannot answer.
Reading behind this section: Evernow: current FAQs · ACOG: hormone therapy for menopause
What the FAQ currently quotes
The FAQ lists a $150 self-pay visit. Its membership choices are $49 month to month, $129 for three months, or $420 for twelve months. The annual amount works out to $35 per month, but a monthly equivalent does not mean the charge is collected monthly.
The membership is described as separate from insurance coverage, while visit and medication billing may follow different rules. Request a clear explanation of the amount due now, the renewal amount, and any prescription or visit charges. Our cost guide offers a way to compare those lines without combining unlike figures.
Reading behind this section: Evernow: current FAQs
Why another page may show another price
An official enrollment landing page reviewed in the same research session displayed a $348 annual offer, equivalent to $29 per month. That differs from the FAQ’s $420 annual figure. It could reflect a particular promotion or enrollment path, but we did not complete a purchase to establish eligibility or final terms.
We therefore do not label either annual figure the guaranteed price for every reader. Save the terms presented to you and ask the company to explain any difference before payment. Confirm whether a discount applies only to the first term and what happens when the plan renews.
Reading behind this section: Evernow: alternate enrollment offer · Evernow: current FAQs · Evernow: care options
Medication is a separate clinical decision
Evernow’s menopause focus does not make hormone therapy appropriate for everyone. The clinician should review symptoms, relevant medical history, medicines, and the benefits and risks of the proposed option. Ask whether a prescription is an FDA-approved formulation or compounded, and why that particular product is being considered.
A benefit attached to some membership tiers should not be assumed to cover every medication, quantity, or person. Read the formulation comparison and risk discussion before treating a membership perk as a reason to choose a specific hormone.
Reading behind this section: Evernow: current FAQs · ACOG: hormone therapy for menopause · FDA: compounding questions and answers
Questions about ongoing care
Clarify who reviews symptoms after treatment begins, what messaging access includes, and when another appointment is needed. Ask how refill decisions are made, whether a change in your state location affects care, and how to obtain records for another clinician. These are practical parts of continuity rather than extras to consider only after a problem.
This review did not test response times, verify appointment slots in every state, or inspect individual prescribing decisions. State availability and clinician authority should be confirmed directly. Our conversation card can help organize a few questions without collecting your private health information.
Reading behind this section: Evernow: current FAQs · HHS: telehealth licensing
Where it fits in a comparison
Evernow may be useful to investigate when you want a menopause-focused online service, but its public pricing needs to be unpacked into the actual care arrangement. Compare it with Midi’s visit-based model using the same assumed follow-up needs and the same distinction between visits and prescriptions.
We do not award an outcome score or repeat promotional success rates as independent evidence. The featured-care shortlist puts CoreAge first because of paid placement and explicitly states that its HRT offering is unconfirmed. None of that ordering should replace a clinical decision about your care.
Reading behind this section: Evernow: current FAQs · Midi Health: pricing and insurance · CoreAge Rx: public treatment catalog
Our source notes
- Evernow: current FAQs
Public care models and prices checked September 23, 2026; medication and visit costs may be separate.
- ACOG: hormone therapy for menopause
Clinical patient guidance; individual history and the actual product label still govern treatment decisions.
- Evernow: alternate enrollment offer
This landing page displays a different annual membership offer from the main FAQ. Confirm the terms of the actual enrollment path.
- Evernow: care options
Provider description of visit and membership routes, not proof of individual eligibility or outcomes.
- FDA: compounding questions and answers
Compounded medication is not FDA-approved.
- HHS: telehealth licensing
Patient location and clinician authorization matter; this is not a state-specific legal opinion.
- Midi Health: pricing and insurance
Provider prices and coverage descriptions; not a verified claim for any individual insurance policy.
- CoreAge Rx: public treatment catalog
Commercial catalog checked September 23, 2026. A current menopausal HRT service was not confirmed.
